The advisory board, authorized in section 381.82, Florida Statutes, advises the State Surgeon General as to the scope of the research program.
The board shall submit its recommendations for proposals to be funded to the State Surgeon General by December 15 of each year. Grants and fellowships shall be awarded by the State Surgeon General, after consultation with the Advisory Board, on the basis of scientific merit.
Other responsibilities of the advisory board may include, but are not limited to, providing advice on program priorities and emphases; assisting in the development of appropriate linkages to non-academic entities, such as voluntary organizations, health care delivery institutions, industry, government agencies, and public officials; and developing and providing oversight regarding mechanisms for the dissemination of research results.
Annually the Alzheimer’s Disease Research Grant Advisory Board submits a fiscal-year progress report, including the following information as required by Florida Statute:
- A list of research projects supported by grants or fellowships awarded under the program
- A list of recipients of program grants or fellowships
- A list of publications in peer-reviewed journals involving research supported by grants or fellowships awarded under the program
- The state ranking and total amount of Alzheimer’s disease research funding currently flowing into the state from the National Institutes of Health
- New grants for Alzheimer’s disease research which were funded based on research supported by grants or fellowships awarded under the program
- Progress toward programmatic goals, particularly in the prevention, diagnosis, treatment, and cure of Alzheimer’s disease
- Recommendations to further the mission of the program
Advisory Board Membership
The Alzheimer’s Disease Research Grant Advisory Board advises the State Surgeon General and Secretary of Health as to the direction and scope of the Alzheimer’s disease research program. Grants and fellowships shall be awarded by the State Surgeon General, after consultation with the board, on the basis of scientific merit. The 11 member board is composed of the following members:
- Two gerontologists
- Two geriatric psychiatrists
- Two geriatricians
- Two neuroscientists
- Three neurologists
Gerontologists
Leilani Doty, PhD, Past Chair
Director, Cognitive and Memory Disorder Clinic and Associate Scientist, Department of Neurology, University of Florida, McKnight Brain Institute
Appointed:01/28/2021
Appointment Ends: 01/28/2025
VACANT
Geriatric Psychiatrists
Josepha Cheong, MD
Malcom Randall VA Medical Center
Appointed: 10/25/2018
Appointment Ends: 10/24/2026
VACANT
Geriatricians
Niharika Suchak, MBBS, MHS, FACP, Chair
Associate Professor, Department of Geriatrics
College of Medicine, Florida State University
Appointed: 01/28/2021
Appointment Ends: 01/28/2025
Mariana B. Dangiolo, MD
Assistant Professor of Family Medicine and Geriatrics, University of Central Florida Health Sciences Campus at Lake Nona
Appointed: 01/28/2021
Appointment Ends: 01/28/2025
Neuroscientists
Eunsook Yu Lee, PhD
Professor of Pharmacology and Toxicology, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University
Appointed: 08/15/2017
Appointment Ends: 08/14/2025
Leonard Petrucelli, PhD, Assistant Chair
Chair, Department of Neuroscience and Professor of Neuroscience, Mayo Clinic Jacksonville
Appointed: 01/28/2021
Appointment Ends: 01/28/2025
Neurologists
James Galvin, MD, MPH
Professor of Neurology and Psychiatry & Behavioral Sciences; Director, Comprehensive Center for Brain Health
University of Miami Miller School of Medicine
Appointed: 11/09/2020
Appointment Ends: 11/08/2024
Neill Graff-Radford, MD
Professor of Neurology
Mayo Clinic Jacksonville
Appointed: 10/01/2014
Appointment Ends: 10/02/2022
Ruth Henchey, MD
Medical Center Clinic
Appointed: 11/09/2020
Appointment Ends: 11/08/2024
Appointments
Appointments
The Alzheimer’s Disease Research Grant Advisory Board is authorized in section 381.82, Florida Statutes.
The board consists of 11 members appointed by the State Surgeon General, including two gerontologists, two geriatric psychiatrists, two geriatricians, two neuroscientists, and three neurologists.
The board members serve 4-year terms. The chair of the board shall be elected from the membership of the board and serve as chair for two years. An appointed member may not serve more than two consecutive terms.
Appointed members must have experience in Alzheimer’s disease or related biomedical research.
The board must follow rigorous guidelines for ethical conduct and adhere to a strict policy regarding conflicts of interest. A member of the board may not participate in any discussion, decision of the board, or panel regarding a research proposal by any firm, entity, or agency the member is associated with as a member of the governing body, as an employee, or if in a contractual arrangement.